We are live on ! Find out more

FLSC

Frazier Life Sciences Acquisition Corp. II Class A Ordinary Shares

FLSC

Market cap $100M

10.35 USD

-0.14

1.33%

At close Updated Oct 16, 4:00 PM EDT

1 day

-1.33%

5 days

1.67%

1 month

0.58%

3 months

0.58%

6 months

0.58%

Year to date

0.58%

1 year

0.58%

5 years

0.58%

10 years

0.58%

About: Frazier Life Sciences Acquisition Corp II is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities.

Financials Shell Companies

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 0%

Neutral 100%

Negative 0%

U.S. IPO Weekly Recap: Biotechs City Therapeutics And Iambic Headline The Week's Pricings

Three IPOs and two SPACs priced this week, and two SPACs submitted filings. No IPOs are currently scheduled for the week ahead as the year's next mega IPO potentially comes into view. Street research is expected to for one company in the week ahead, and four lock-up periods will be expiring.

U.S. IPO Weekly Recap: Biotechs City Therapeutics And Iambic Headline The Week's Pricings

Frazier Life Sciences Acquisition Corp. II Announces Completion of $75,000,000 Initial Public Offering

PALO ALTO, Calif.--(BUSINESS WIRE)--Frazier Life Sciences Acquisition Corp. II (the “Company”), a special purpose acquisition company, announced today the closing of its initial public offering of 7,500,000 Class A ordinary shares at a price of $10.00 per share. The Class A ordinary shares are listed on The Nasdaq Capital Market and began trading under the ticker symbol “FLSC” as of October 14, 2026. The Company was formed for the purpose of effecting a merger, amalgamation, share exchange, ass.

Frazier Life Sciences Acquisition Corp. II Announces Completion of $75,000,000 Initial Public Offering

See News Rankings

Price charts implemented using Lightweight Charts™